| MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway | |
| Cheng Du1; Xiaomin Yi2; Wenchao Liu2; Tao Han1; Zhaozhe Liu1; Zhenyu Ding1; Zhendong Zheng1; Ying Piao1; Jianlin Yuan2; Yaling Han1; Manjiang Xie2; Xiaodong Xie1 | |
| 2014-01-01 | |
| 发表期刊 | BMC Cancer
 |
| ISSN | 1471-2407 |
| 卷号 | 14期号:1 |
| 摘要 | Trastuzumab resistance is almost inevitable in the management of human epidermal growth factor receptor (HER) 2 positive breast cancer, in which phosphatase and tensin homolog deleted from chromosome 10 (PTEN) loss is implicated. Since metadherin (MTDH) promotes malignant phenotype of breast cancer, we sought to define whether MTDH promotes trastuzumab resistance by decreasing PTEN expression through an NFκB-dependent pathway. |
| 语种 | 英语 |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.imr.ac.cn/handle/321006/159390 |
| 专题 | 中国科学院金属研究所 |
| 作者单位 | 1.Institute of Metal Research, Chinese Academy of Sciences 2.中国人民解放军第四军医大学 3.Department of Urology |
| 推荐引用方式 GB/T 7714 | Cheng Du,Xiaomin Yi,Wenchao Liu,et al. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway[J]. BMC Cancer,2014,14(1). |
| APA | Cheng Du.,Xiaomin Yi.,Wenchao Liu.,Tao Han.,Zhaozhe Liu.,...&Xiaodong Xie.(2014).MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.BMC Cancer,14(1). |
| MLA | Cheng Du,et al."MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway".BMC Cancer 14.1(2014). |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论